Figure 14 shows timeliness of the 2nd dose of MMR vaccine by Indigenous status for the cohort born in 2006. In contrast to the 3rd dose of DTPa and the 1st dose of MMR, analysis of timeliness of immunisation for a vaccine due at 48 months of age, the 2nd dose of MMR, showed a much smaller differential in delay in receiving this vaccine between non-Indigenous children and Indigenous children, with a 5.4% differential at < 49 months of age.